181P SELECT: A phase II randomized trial evaluating 2 doses of vopratelimab (V) + pimivalimab (P) vs P in TISvopra selected patients (pts)

Saved in:
Bibliographic Details
Published inImmuno-oncology technology Vol. 16; p. 100293
Main Authors Gumus, M., Sukalinskaya, A., Andric, Z.G., Cheshuk, V., Ciuleanu, T-E., Sezgin Goksu, S., Cil, T., Cicin, I., Bulat, I.V., Ostapenko, Y.V., Penkov, K.D., Hart, C., Lai, M., Chaao, B., Jimenez, J., Sepahi, A., Shi, G., Trott, S., Hooper, E.
Format Journal Article
LanguageEnglish
Published 01.12.2022
Online AccessGet full text

Cover

More Information
ISSN:2590-0188
2590-0188
DOI:10.1016/j.iotech.2022.100293